Mona Askar
Impact in
- Endocrinology top 0.5%
- Escherichia coli research studies
- Infectious Diseases top 5%
- Viral gastroenteritis research and epidemiology
- Clostridium difficile and Clostridium perfringens research
Papers in
-
- Escherichia coli research studies 2
-
- Viral gastroenteritis research and epidemiology 2
- Co-authors
- Klaus Dieter Stark (3 shared papers)Mirko S. Faber (1 shared paper)Hendrik Wilking (3 shared papers)Christina Frank (2 shared papers)Andreas Nitsche (1 shared paper)Anja Takla (1 shared paper)Andreas Alois Kurth (1 shared paper)Lars Schaade (1 shared paper)
In The Last Decade
Mona Askar
9 papers receiving 1.1k citations
Mona Askar's Hit Papers
Peers
Comparison fields: 5 of 86
- Endocrinology 580
- Infectious Diseases 514
- Biotechnology 144
- Molecular Medicine 74
- Food Science 221
Countries citing papers authored by Mona Askar
This map shows the geographic impact of Mona Askar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mona Askar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mona Askar more than expected).
Fields of papers citing papers by Mona Askar
This network shows the impact of papers produced by Mona Askar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mona Askar. The network helps show where Mona Askar may publish in the future.
Co-authors
The 25 scholars most cited alongside Mona Askar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Epidemic Profile of Shiga-Toxin–ProducingEscherichia coliO104:H4 Outbreak in Germany Hit paper breakdown → | 2011 | 920 |
| 2 | 2015 | 67 | |
| 3 | 2018 | 49 | |
| 4 | 2012 | 39 | |
| 5 | Comparison of phenytoin with auranofin and chloroquine in rheumatoid arthritis--a double blind study. | 1995 | 10 |
| 6 | 2012 | 9 | |
| 7 | 2025 | 7 | |
| 8 | 2013 | 5 | |
| 9 | 2025 | 1 | |
| 10 | 2025 | 0 | |
| 11 | 2026 | 0 |
About Mona Askar
Mona Askar is a scholar working on Endocrinology, Infectious Diseases, Epidemiology, Parasitology and Small Animals, having authored 11 papers that have together received 1.1k indexed citations. Recurring topics across this work include Viral gastroenteritis research and epidemiology (2 papers), Influenza Virus Research Studies (2 papers), Cervical Cancer and HPV Research (2 papers), Escherichia coli research studies (2 papers), Hepatitis Viruses Studies and Epidemiology (1 paper), Diabetes and associated disorders (1 paper), Parasitic Infections and Diagnostics (1 paper) and Respiratory viral infections research (1 paper). The work is most often cited by research in Endocrinology (580 citations), Infectious Diseases (514 citations), Biotechnology (144 citations), Molecular Medicine (74 citations) and Food Science (221 citations). Mona Askar has collaborated with scholars based in Germany, Sweden and Belgium. Frequent co-authors include Klaus Dieter Stark, Mirko S. Faber, Hendrik Wilking, Christina Frank, Andreas Nitsche, Anja Takla, Andreas Alois Kurth, Lars Schaade, Tanja Ducomble and Maximilian Gertler. Their work appears in journals such as Emerging infectious diseases, Vaccine, Reviews in Medical Virology, BMJ Open and EClinicalMedicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.